Thermo Fisher Scientific Debt to Equity Ratio 2011-2025 | TMO
Current and historical debt to equity ratio values for Thermo Fisher Scientific (TMO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Thermo Fisher Scientific debt/equity for the three months ending September 30, 2025 was 0.62.
| Thermo Fisher Scientific Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-09-30 | $52.00B | $51.02B | 1.02 |
| 2025-06-30 | $50.75B | $50.48B | 1.01 |
| 2025-03-31 | $49.68B | $49.36B | 1.01 |
| 2024-12-31 | $47.77B | $49.55B | 0.96 |
| 2024-09-30 | $51.39B | $48.97B | 1.05 |
| 2024-06-30 | $51.08B | $47.42B | 1.08 |
| 2024-03-31 | $51.59B | $45.50B | 1.13 |
| 2023-12-31 | $52.00B | $46.72B | 1.11 |
| 2023-09-30 | $51.71B | $45.35B | 1.14 |
| 2023-06-30 | $50.30B | $43.80B | 1.15 |
| 2023-03-31 | $52.35B | $42.31B | 1.24 |
| 2022-12-31 | $53.12B | $44.03B | 1.21 |
| 2022-09-30 | $46.93B | $43.61B | 1.08 |
| 2022-06-30 | $48.23B | $42.35B | 1.14 |
| 2022-03-31 | $51.73B | $41.02B | 1.26 |
| 2021-12-31 | $54.27B | $40.86B | 1.33 |
| 2021-09-30 | $34.89B | $38.71B | 0.90 |
| 2021-06-30 | $30.84B | $36.85B | 0.84 |
| 2021-03-31 | $30.87B | $35.06B | 0.88 |
| 2020-12-31 | $34.54B | $34.52B | 1.00 |
| 2020-09-30 | $32.24B | $31.82B | 1.01 |
| 2020-06-30 | $31.72B | $29.88B | 1.06 |
| 2020-03-31 | $30.13B | $28.56B | 1.06 |
| 2019-12-31 | $28.71B | $29.68B | 0.97 |
| 2019-09-30 | $27.37B | $29.36B | 0.93 |
| 2019-06-30 | $29.24B | $28.73B | 1.02 |
| 2019-03-31 | $27.90B | $27.69B | 1.01 |
| 2018-12-31 | $28.65B | $27.59B | 1.04 |
| 2018-09-30 | $28.19B | $26.89B | 1.05 |
| 2018-06-30 | $28.96B | $26.45B | 1.10 |
| 2018-03-31 | $30.46B | $26.12B | 1.17 |
| 2017-12-31 | $31.26B | $25.41B | 1.23 |
| 2017-09-30 | $31.28B | $24.70B | 1.27 |
| 2017-06-30 | $24.12B | $22.39B | 1.08 |
| 2017-03-31 | $24.42B | $21.80B | 1.12 |
| 2016-12-31 | $24.37B | $21.54B | 1.13 |
| 2016-09-30 | $26.35B | $21.66B | 1.22 |
| 2016-06-30 | $20.99B | $21.26B | 0.99 |
| 2016-03-31 | $22.03B | $20.92B | 1.05 |
| 2015-12-31 | $19.48B | $21.35B | 0.91 |
| 2015-09-30 | $20.30B | $20.85B | 0.97 |
| 2015-06-30 | $21.10B | $20.68B | 1.02 |
| 2015-03-31 | $21.94B | $19.92B | 1.10 |
| 2014-12-31 | $22.30B | $20.55B | 1.09 |
| 2014-09-30 | $22.18B | $20.51B | 1.08 |
| 2014-06-30 | $23.66B | $20.66B | 1.15 |
| 2014-03-31 | $25.70B | $20.43B | 1.26 |
| 2013-12-31 | $15.01B | $16.86B | 0.89 |
| 2013-09-30 | $11.84B | $16.44B | 0.72 |
| 2013-06-30 | $11.83B | $15.80B | 0.75 |
| 2013-03-31 | $11.81B | $15.60B | 0.76 |
| 2012-12-31 | $11.98B | $15.47B | 0.78 |
| 2012-09-30 | $12.29B | $15.29B | 0.80 |
| 2012-06-30 | $11.27B | $15.09B | 0.75 |
| 2012-03-31 | $11.53B | $15.29B | 0.75 |
| 2011-12-31 | $11.80B | $15.04B | 0.78 |
| 2011-09-30 | $11.80B | $15.20B | 0.78 |
| 2011-06-30 | $8.41B | $15.67B | 0.54 |
| 2011-03-31 | $8.18B | $15.26B | 0.54 |
| 2010-12-31 | $5.99B | $15.36B | 0.39 |
| 2010-09-30 | $6.14B | $15.40B | 0.40 |
| 2010-06-30 | $5.94B | $15.35B | 0.39 |
| 2010-03-31 | $6.15B | $15.48B | 0.40 |
| 2009-12-31 | $6.19B | $15.43B | 0.40 |
| 2009-09-30 | $6.02B | $15.40B | 0.39 |
| 2009-06-30 | $6.08B | $15.08B | 0.40 |
| 2009-03-31 | $6.04B | $14.99B | 0.40 |
| 2008-12-31 | $6.16B | $14.93B | 0.41 |
| 2008-09-30 | $6.46B | $15.14B | 0.43 |
| 2008-06-30 | $6.61B | $15.07B | 0.44 |
| 2008-03-31 | $6.71B | $14.79B | 0.45 |
| 2007-12-31 | $6.72B | $14.49B | 0.46 |
| 2007-09-30 | $6.73B | $14.44B | 0.47 |
| 2007-06-30 | $6.74B | $14.53B | 0.46 |
| 2007-03-31 | $6.94B | $14.23B | 0.49 |
| 2006-12-31 | $7.35B | $13.91B | 0.53 |
| 2006-09-30 | $1.38B | $2.82B | 0.49 |
| 2006-06-30 | $1.44B | $2.74B | 0.53 |
| 2006-03-31 | $1.37B | $2.87B | 0.48 |
| 2005-12-31 | $1.46B | $2.79B | 0.52 |
| 2005-09-30 | $1.39B | $2.76B | 0.50 |
| 2005-06-30 | $1.44B | $2.69B | 0.54 |
| 2005-03-31 | $0.88B | $2.68B | 0.33 |
| 2004-12-31 | $0.91B | $2.67B | 0.34 |
| 2004-09-30 | $0.94B | $2.43B | 0.39 |
| 2004-06-30 | $1.04B | $2.45B | 0.42 |
| 2004-03-31 | $1.03B | $2.43B | 0.42 |
| 2003-12-31 | $1.01B | $2.38B | 0.42 |
| 2003-09-30 | $0.89B | $2.24B | 0.40 |
| 2003-06-30 | $1.09B | $2.19B | 0.50 |
| 2003-03-31 | $1.33B | $2.08B | 0.64 |
| 2002-12-31 | $1.62B | $2.03B | 0.80 |
| 2002-09-30 | $1.71B | $1.96B | 0.87 |
| 2002-06-30 | $1.78B | $2.01B | 0.89 |
| 2002-03-31 | $1.88B | $2.01B | 0.94 |
| 2001-12-31 | $1.92B | $1.91B | 1.01 |
| 2001-09-30 | $2.13B | $2.25B | 0.95 |
| 2001-06-30 | $2.24B | $2.46B | 0.91 |
| 2001-03-31 | $2.31B | $2.47B | 0.94 |
| 2000-12-31 | $2.33B | $2.53B | 0.92 |
| 2000-09-30 | $2.47B | $2.57B | 0.96 |
| 2000-06-30 | $2.67B | $2.48B | 1.08 |
| 2000-03-31 | $3.16B | $2.01B | 1.57 |
| 1999-12-31 | $3.17B | $2.01B | 1.57 |
| 1999-09-30 | $4.04B | $2.03B | 1.99 |
| 1999-06-30 | $3.98B | $1.95B | 2.04 |
| 1999-03-31 | $4.14B | $2.21B | 1.88 |
| 1998-12-31 | $4.08B | $2.25B | 1.82 |
| 1998-09-30 | $4.02B | $2.22B | 1.81 |
| 1998-06-30 | $4.08B | $2.36B | 1.73 |
| 1998-03-31 | $4.08B | $2.03B | 2.01 |
| 1997-12-31 | $3.80B | $2.00B | 1.90 |
| 1997-09-30 | $3.80B | $1.79B | 2.12 |
| 1997-06-30 | $3.45B | $1.86B | 1.86 |
| 1997-03-31 | $3.51B | $1.83B | 1.91 |
| 1996-12-31 | $3.31B | $1.83B | 1.81 |
| 1996-09-30 | $3.25B | $1.70B | 1.92 |
| 1996-06-30 | $3.33B | $1.57B | 2.13 |
| 1996-03-31 | $3.22B | $1.42B | 2.26 |
| 1995-12-31 | $2.43B | $1.32B | 1.84 |
| 1995-09-30 | $2.29B | $1.22B | 1.89 |
| 1995-06-30 | $2.19B | $1.12B | 1.95 |
| 1995-03-31 | $2.08B | $1.07B | 1.94 |
| 1994-12-31 | $2.05B | $1.01B | 2.04 |
| 1994-09-30 | $2.01B | $0.97B | 2.08 |
| 1994-06-30 | $2.04B | $0.89B | 2.29 |
| 1994-03-31 | $1.69B | $0.88B | 1.93 |
| 1993-12-31 | $1.62B | $0.86B | 1.88 |
| 1993-09-30 | $1.19B | $0.85B | 1.40 |
| 1993-06-30 | $1.10B | $0.59B | 1.88 |
| 1993-03-31 | $1.11B | $0.58B | 1.93 |
| 1992-12-31 | $1.10B | $0.55B | 1.98 |
| 1992-09-30 | $1.05B | $0.57B | 1.83 |
| 1992-06-30 | $0.71B | $0.55B | 1.30 |
| 1992-03-31 | $0.70B | $0.53B | 1.32 |
| 1991-12-31 | $0.59B | $0.48B | 1.23 |
| 1991-09-30 | $0.52B | $0.46B | 1.12 |
| 1991-06-30 | $0.52B | $0.35B | 1.47 |
| 1991-03-31 | $0.54B | $0.32B | 1.70 |
| 1990-12-31 | $0.50B | $0.32B | 1.57 |
| 1990-09-30 | $0.49B | $0.29B | 1.68 |
| 1990-06-30 | $0.46B | $0.29B | 1.59 |
| 1990-03-31 | $0.32B | $0.23B | 1.37 |
| 1989-12-31 | $0.37B | $0.24B | 1.56 |
| 1989-09-30 | $0.31B | $0.21B | 1.47 |
| 1989-06-30 | $0.30B | $0.20B | 1.47 |
| 1989-03-31 | $0.26B | $0.20B | 1.30 |
| 1988-12-31 | $0.31B | $0.18B | 1.70 |
| 1988-09-30 | $0.28B | $0.17B | 1.62 |
| 1988-06-30 | $0.24B | $0.17B | 1.42 |
| 1988-03-31 | $0.24B | $0.17B | 1.41 |
| 1987-12-31 | $0.24B | $0.16B | 1.48 |
| 1987-09-30 | $0.23B | $0.16B | 1.42 |
| 1987-06-30 | $0.23B | $0.15B | 1.47 |
| 1987-03-31 | $0.14B | $0.15B | 0.91 |
| 1986-12-31 | $0.14B | $0.15B | 0.98 |
| 1985-12-31 | $0.11B | $0.10B | 1.12 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $218.080B | $42.879B |
| Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $204.228B | 79.90 |
| IDEXX Laboratories (IDXX) | United States | $57.966B | 57.57 |
| Edwards Lifesciences (EW) | United States | $48.734B | 32.68 |
| Alcon (ALC) | Switzerland | $39.474B | 26.68 |
| IQVIA Holdings (IQV) | United States | $38.699B | 21.58 |
| Mettler-Toledo (MTD) | United States | $29.312B | 34.29 |
| STERIS (STE) | Ireland | $25.459B | 26.28 |
| DexCom (DXCM) | United States | $25.293B | 34.87 |
| Waters (WAT) | United States | $23.672B | 31.31 |
| Hologic (HOLX) | United States | $16.720B | 17.57 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.802B | 0.00 |
| Globus Medical (GMED) | United States | $11.744B | 24.65 |
| Penumbra (PEN) | United States | $11.189B | 78.71 |
| Masimo (MASI) | United States | $7.417B | 23.77 |
| Glaukos (GKOS) | United States | $6.172B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.867B | 18.64 |
| Teleflex (TFX) | United States | $5.264B | 8.39 |
| TransMedics (TMDX) | United States | $4.788B | 56.72 |
| Veracyte (VCYT) | United States | $3.775B | 43.02 |
| LivaNova (LIVN) | United Kingdom | $3.456B | 18.67 |
| Alphatec Holdings (ATEC) | United States | $3.154B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.448B | 11.49 |
| Elekta AB (EKTAY) | Sweden | $2.181B | 20.40 |
| Artivion (AORT) | United States | $2.155B | 98.87 |
| PROCEPT BioRobotics (PRCT) | United States | $1.854B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.740B | 15.19 |
| UFP Technologies (UFPT) | United States | $1.694B | 22.37 |
| Tandem Diabetes Care (TNDM) | United States | $1.351B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.338B | 0.00 |
| AxoGen (AXGN) | United States | $1.307B | 0.00 |
| IRadimed (IRMD) | United States | $1.185B | 56.47 |
| OPKO Health (OPK) | United States | $1.052B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.051B | 5.69 |
| Pulse Biosciences (PLSE) | United States | $0.914B | 0.00 |
| SiBone (SIBN) | United States | $0.832B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.734B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.630B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.589B | 34.23 |
| AngioDynamics (ANGO) | United States | $0.556B | 0.00 |
| NeuroPace (NPCE) | United States | $0.555B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.525B | 10.47 |
| RxSight (RXST) | United States | $0.488B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.453B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.450B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.422B | 11.64 |
| ClearPoint Neuro (CLPT) | United States | $0.400B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.341B | 56.82 |
| Alpha Tau Medical (DRTS) | Israel | $0.329B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.310B | 2.33 |
| Spectral Diagnostics (EDTXF) | Canada | $0.270B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.252B | 0.00 |
| CVRx (CVRX) | United States | $0.243B | 0.00 |
| 908 Devices (MASS) | United States | $0.225B | 0.00 |
| Inogen (INGN) | United States | $0.188B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.184B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.177B | 0.00 |
| Solana (HSDT) | United States | $0.172B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.171B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.167B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.143B | 0.00 |
| LENSAR (LNSR) | United States | $0.125B | 0.00 |
| Accuray (ARAY) | United States | $0.117B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.110B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.095B | 0.00 |
| Neuronetics (STIM) | United States | $0.092B | 0.00 |
| Hyperfine (HYPR) | United States | $0.091B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.090B | 0.00 |
| InspireMD (NSPR) | United States | $0.081B | 0.00 |
| DarioHealth (DRIO) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.074B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.066B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.054B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.050B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Envoy Medical (COCH) | United States | $0.023B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.022B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.33 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |